ARS Pharmaceuticals to Participate in the 2024 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

ARS Pharmaceuticals (Nasdaq: SPRY), a company focused on protecting people from severe allergic reactions, announced its participation in the 2024 Wedbush PacGrow Healthcare Conference. The event will take place on August 13-14, 2024 in New York City. Company management will meet with investors on Wednesday, August 14, 2024, for one-on-one discussions.

This conference provides ARS Pharmaceuticals with an opportunity to showcase its work in empowering at-risk patients and caregivers against anaphylaxis. The company's presence at this healthcare-focused event could potentially attract investor interest and highlight its position in the biopharmaceutical sector.

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced its participation in the 2024 Wedbush PacGrow Healthcare Conference being held August 13-14, 2024 in New York City. Company management will participate in one-on-one meetings with investors on Wednesday, August 14, 2024.

About ARS Pharmaceuticals, Inc.
ARS Pharma is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The Company is developing neffy (also referred to as ARS-1), an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications and insect bites that could lead to life-threatening anaphylaxis. For more information, visit www.ars-pharma.com.

ARS Investor Contacts:
Justin Chakma
ARS Pharmaceuticals
justinc@ars-pharma.com

ARS Media Contact:
Christy Curran
Sam Brown Inc.
christycurran@sambrown.com

FAQ

When is ARS Pharmaceuticals (SPRY) participating in the Wedbush PacGrow Healthcare Conference?

ARS Pharmaceuticals (SPRY) is participating in the Wedbush PacGrow Healthcare Conference on August 13-14, 2024, with company management holding one-on-one meetings with investors on Wednesday, August 14, 2024.

Where is the 2024 Wedbush PacGrow Healthcare Conference being held?

The 2024 Wedbush PacGrow Healthcare Conference is being held in New York City.

What is the focus of ARS Pharmaceuticals (SPRY)?

ARS Pharmaceuticals (SPRY) is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis.

How will ARS Pharmaceuticals (SPRY) engage with investors at the conference?

ARS Pharmaceuticals (SPRY) management will participate in one-on-one meetings with investors on Wednesday, August 14, 2024, during the conference.